2-chloro-N-methylbenzenesulfonanilide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-chloro-N-methylbenzenesulfonanilide
• 英文别名: 2-chloro-N-methyl-N-phenylbenzenesulfonamide
• 化学式: C₁₃H₁₂ClNO₂S
• 分子量: 281.76
• InChiKey: UTYOJNNXQXPIOG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  N-甲基苯胺 、 2-氯苯磺酰氯 、 sodium hydroxide 以2-chloro-N-methylbenzenesulfonanilide is formed as a viscous yellow liquid的产率得到2-chloro-N-methylbenzenesulfonanilide
  参考文献：
  名称：

  Diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus

  摘要：

  根据本发明，现提供选择自以下组的式子的新型抗HIV化合物：其中R1是氢或C1-C4烷基；R2是氢、C1-C4烷基、C1-C4烷氧基或卤素；R3是氢、羟基、C1-C4烷基、C1-C4烷氧基或卤素；R4是氢或卤素，R5是氢、C1-C4烷氧基、硝基、卤素或卤代烷基；R6是氢或硝基；R7是氢或C1-C4烷基、C1-C4烷氧基、硝基或卤素；R8是氢、羟基、C1-C4烷基、C1-C4烷氧基或卤素；R9是氢或硝基；R10是氢或卤素；R11是氢、C1-C4胺基；R12是氢、C1-C4烷基或卤素；R13是氢、C1-C4胺基；R14是氢或卤素；R15是氢、C1-C4烷氧基、C1-C4卤代烷基、硝基或卤素；R16是氢或硝基；R17是氢、C1-C4烷基、C1-C4烷氧基、硝基或卤素；R18是氢、C1-C4烷氧基、羟基或卤素；R19是氢或硝基；R20是氢或卤素，或其药学上可接受的盐。

  公开号：

  US06303630B1

文献信息

• Diarylsulfone non-nucleoside reverse transcriptase inhibitors of human
  申请人：University of the Sciences in Philadelphia

  公开号：US06063790A1

  公开（公告）日：2000-05-16

  In accordance with the present invention, there is now provided novel anti-HIV compounds of the formulae selected from the group consisting of: ##STR1## wherein R.sub.1 is hydrogen or C.sub.1 -C.sub.4 alkyl; R.sub.2 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; R.sub.3 is hydrogen, hydroxy, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; R.sub.4 is hydrogen or halogen, R.sub.5 is hydrogen; C.sub.1 -C.sub.4 alkoxy, nitro, halogen or haloalkyl; R.sub.6 is hydrogen or nitro; R.sub.7 is hydrogen or C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro or halogen; R.sub.8 is hydrogen, hydroxy, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; R.sub.9 is hydrogen or nitro; R.sub.10 is hydrogen or halogen; R.sub.11 is hydrogen, C.sub.1 -C.sub.4 amine; R.sub.12 is hydrogen, C.sub.1 -C.sub.4 alkyl or halogen; R.sub.13 is hydrogen, C.sub.1 -C.sub.4 amine; R.sub.14 is hydrogen or halogen; R.sub.15 is hydrogen, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 haloalkyl, nitro, or halogen; R.sub.16 is hydrogen or nitro; R.sub.17 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro or halogen; R.sub.18 is hydrogen, C.sub.1 -C.sub.4 alkoxy, hydroxy, or halogen; R.sub.19 is hydrogen or nitro; and R.sub.20 is hydrogen or halogen and R.sub.21 is hydrogen or NO.sub.2, or a pharmaceutically acceptable salt thereof.

  根据本发明，现提供一种新型抗HIV化合物，其化学式选自以下组合：##STR1## 其中R.sub.1是氢或C.sub.1-C.sub.4烷基；R.sub.2是氢，C.sub.1-C.sub.4烷基，C.sub.1-C.sub.4烷氧基或卤素；R.sub.3是氢，羟基，C.sub.1-C.sub.4烷基，C.sub.1-C.sub.4烷氧基或卤素；R.sub.4是氢或卤素，R.sub.5是氢；C.sub.1-C.sub.4烷氧基，硝基，卤素或卤代烷基；R.sub.6是氢或硝基；R.sub.7是氢或C.sub.1-C.sub.4烷基，C.sub.1-C.sub.4烷氧基，硝基或卤素；R.sub.8是氢，羟基，C.sub.1-C.sub.4烷基，C.sub.1-C.sub.4烷氧基或卤素；R.sub.9是氢或硝基；R.sub.10是氢或卤素；R.sub.11是氢，C.sub.1-C.sub.4胺基；R.sub.12是氢，C.sub.1-C.sub.4烷基或卤素；R.sub.13是氢，C.sub.1-C.sub.4胺基；R.sub.14是氢或卤素；R.sub.15是氢，C.sub.1-C.sub.4烷氧基，C.sub.1-C.sub.4卤代烷基，硝基或卤素；R.sub.16是氢或硝基；R.sub.17是氢，C.sub.1-C.sub.4烷基，C.sub.1-C.sub.4烷氧基，硝基或卤素；R.sub.18是氢，C.sub.1-C.sub.4烷氧基，羟基或卤素；R.sub.19是氢或硝基；R.sub.20是氢或卤素，R.sub.21是氢或NO.sub.2，或其药学上可接受的盐。
• EP1011652A4
  申请人：——

  公开号：EP1011652A4

  公开（公告）日：2004-12-22
• NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS
  申请人：University of the Sciences in Philadelphia

  公开号：EP1011652A1

  公开（公告）日：2000-06-28
• US6063790A
  申请人：——

  公开号：US6063790A

  公开（公告）日：2000-05-16
• US6303630B1
  申请人：——

  公开号：US6303630B1

  公开（公告）日：2001-10-16